SNBL USA, a provider of safety assessment services, has appointed Mark Walker as Field Technical Director. Based on the East Coast, Walker will be responsible for providing scientific and regulatory guidance to support preclinical development programmes.
Walker has more than 20 years of contract research organisation experience within the preclinical toxicology and drug development industries focusing on primate toxicology, integrative preclinical programme design and regulatory interactions for investigational new drug (IND) applications. He has successfully led the development, validation and commercialisation of specialised toxicology capabilities within a GLP laboratory environment, including both in vivo and laboratory based, in vitro models and services.
Walker joins SNBL USA from Walker Consulting Services where he provided preclinical drug development and outsourcing support services. He has also held various scientific and managerial positions including: Vice President of toxicology, pathology and laboratory animal medicine at Frontier BioSciences, Senior Director of scientific and laboratory operations at Charles River Laboratories and Senior Scientific Advisor and Senior Principal Scientist at Covance.
